Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01234675 · ClinicalTrials.gov registry record · Phase 4
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
A Phase 4 study of Sleep and Fibromyalgia, sponsored by Mansoor Ahmed M.D..
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT01234675 is a Phase 4 study of Sleep and Fibromyalgia that has completed, run by Mansoor Ahmed M.D.. The registered enrollment target is 19 participants, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01234675, a Phase 4 study of Sleep and Fibromyalgia, has completed, sponsored by Mansoor Ahmed M.D..
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Fibromyalgia is a condition of chronic widespread pain, sleep disturbance and fatigue. Most of the patients with fibromyalgia complain of either non-restorative sleep or complaints of disturbed sleep due to pain. The study aimed at examining the effects of milnacipran on sleep disturbance in patients with fibromyalgia. The study is a randomized, double-blind, placebo controlled, two way crossover polysomnography (PSG) study to explore the effects of milnacipran on sleep disturbance. Patients received either milnacipran 50 mg twice a day (BID) or matching placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Milnacipran
Study Locations (1)
Ohio
- Cleveland Sleep Research Center - Middleburg Heights
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2010-11 |
| Est. Completion | 2014-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01234675
The ClinicalTrials.gov registry entry for NCT01234675 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,166-participant average among 151 other Sleep trials with a reported enrollment target (100% lower). The listed sponsor is Mansoor Ahmed M.D., which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01234675 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01234675 about?
NCT01234675 is a clinical study titled "The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia". Fibromyalgia is a condition of chronic widespread pain, sleep disturbance and fatigue. Most of the patients with fibromyalgia complain of either non-restorative sleep or complaints of disturbed sleep due to pain. The study aimed at examining the effects of milnacipran on sleep disturbance in patient...
What is the current status of trial NCT01234675?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2010-11. Estimated completion is 2014-02.
What conditions does trial NCT01234675 study?
This clinical trial studies the following conditions: Sleep, Fibromyalgia, Sleep Disorders.
What interventions are being tested in trial NCT01234675?
The interventions under investigation include: Placebo (DRUG), Milnacipran (DRUG).
Who is sponsoring clinical trial NCT01234675?
This trial is sponsored by Mansoor Ahmed M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01234675 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Magnesium-L-Threonate for Sleep Quality Post-Arthroplasty
RECRUITING · Phase 4
-
Evaluation of a Neurostimulation Device for Insomnia: A Randomized Trial
ACTIVE NOT RECRUITING · Phase 4
-
Hypnotic Medications and Memory: Effect of Drug Exposure During the Night
COMPLETED · Phase 4
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
Research Framework Exploring Sleep Health
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.